Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia

Clinical trial NCT01861314 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01861314
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia Post Cytotoxic Therapy Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia

Start date: 2013-07-03
Primary completion: 2015-11-06
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.